MiRNAs Evaluating Lymphocyte Proliferation and Apoptosis as Well as Prognosis of Sepsis
NCT02756559 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2016-05-02
Summary
Sepsis is a systemic inflammatory reaction caused by infection, trauma, etc. In the process of sepsis, the apoptosis of lymphocyte serves as a vital factor of immune dysfunction. Micro-RNAs (miRNAs) are endogenous small non-coding RNA molecules. Our previous studies have showed the diagnostic and prognostic value of a series circulant miRNAs in human serum in sepsis. The present research further study the regulatory mechanism of those miRNAs in lymphocyte in sepsis. Our research is based on the clinical value of miR-223, miR-15a, miR-16. The investigators discuss the potential role of miR-223, miR-15a, miR-16 in regulating the proliferation and apoptosis of lymphocyte in sepsis and aim to find new targets for sepsis treatment.
Conditions
- T Lymphocyte Disorder
Sponsors & Collaborators
-
Lixin Xie
lead OTHER
Principal Investigators
-
Lixin Xie, Clinical Professor · Chinese PLA General Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2017-06-30
- Completion
- 2017-12-31
Countries
- China
Study Locations
More Related Trials
-
Co-inhibitory Molecules on Treg and miR-155-5p in Patients With Sepsis
NCT05126537 ·Status: UNKNOWN
-
Modulation of Molecular Fingerprinting in Pediatric Sepsis
NCT02055105 ·Status: RECRUITING
-
miRNA in Septic Acute Kidney Injury
NCT06498336 ·Status: RECRUITING
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
NCT02887274 ·Status: UNKNOWN
-
Function of Circulating Exosomes in Sepsis-induced Immunosuppression
NCT04979767 ·Status: UNKNOWN
-
Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With Sepsis
NCT02180009 ·Status: COMPLETED
-
A Study of Exosome Proteomics and Hemodynamics in Sepsis
NCT03267160 ·Status: COMPLETED
-
The Efficacy and Safety of Ta1 for Sepsis
NCT02867267 ·Status: COMPLETED ·Phase: PHASE3
-
Endotoxin Activity Assay and Microcirculation in Severe Sepsis
NCT02452138 ·Status: UNKNOWN
-
Immunoregulatory Therapy for 2019-nCoV
NCT04268537 ·Status: UNKNOWN ·Phase: PHASE2
-
Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis
NCT06287684 ·Status: RECRUITING
-
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 ·Status: COMPLETED
-
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
NCT06446947 ·Status: RECRUITING
-
Dendritic Cells-Derived Exosomes in Human Sepsis
NCT02957279 ·Status: UNKNOWN
-
Expression of TIM-3 on Lymphocytes in Sepsis
NCT02319876 ·Status: UNKNOWN
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
the Effect of Gut Microbiota on the Prognosis of Sepsis
NCT02768324 ·Status: UNKNOWN
-
Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients
NCT02883218 ·Status: COMPLETED
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
Detection Of Monocytes/Macrophages Function And Tim-3 Expression In Septic Patients
NCT01801839 ·Status: COMPLETED
-
Midkine and ACE-Ang II Induced Endothelial Injury in Sepsis
NCT02605681 ·Status: COMPLETED
-
Risk Factors for Adverse Outcomes in Sepsis
NCT06541600 ·Status: COMPLETED
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT01535534 ·Status: UNKNOWN
-
The Effect and Mechanism of lncRNA NBR2 Regulating Endothelial Pyroptosis by Targeting GSDMD in Sepsis
NCT04427371 ·Status: UNKNOWN